[Review] Understanding the Measles Virus at 70 Years: From Cellular Mechanisms to Immunisation, 1954-2024
Published: July 16, 2024
Measles
virus
(_Morbillivirus_
abbreviated
as
MV,
but
more
recently
MeV)
is
the
causal
agent
of
disease,
thought
to
have
existed
at
least
4000
years
ago,
affecting
predominantly
infants,
also
immunocompromised
individuals
and
others
remaining
a
public
health
issue
today
globally.
In
this
review,
we
are
discussing
historical
background
about
MeV
infection
modern–day
research,
then
delving
into
disease
what
known
immunisation
against
disease.
We
elucidate
viral
structure
function
proteins.
The
genomic
stability
particle
suggestive
that
third
pathogen
with
potential
be
eradicated
(after
Variola
Rinderpest
viruses)
requires
further
biological
immunological
clarification.
Here
therefore
covers
bow
from
mechanism
clinical
aspects
touching
topics
like
cellular
receptor–associated
factors
immunology
infection.
highlight
actual
knowledge
innate
immune
response
during
infection,
including
chemokine
cytokine
expression
finalised
by
current
understanding
adaptive
responses
MeV.
Language: Английский
[Short Communication] Measles: 1963-2023, Immunology of a Morbillivirus
Published: Nov. 6, 2023
Measles
is
a
virus,
abbreviated
to
MeV,
that
has
long
been
known
be
causal
in
infant
disease
and
affect
mortality,
remaining
public
health
issue
of
priority.
The
virion
defined
biologically
within
the
Family
_Paraxmyxoviridae_,
Genus
_Morbillivirus_
Species
_MeaslesMorbillivirus.
_Similar
other
viral
infections,
MeV
an
airborne
infection
with
particle
composed
negative
(-ve)
sense
single-stranded
(ss)
ribonucleic
acid
(RNA)
genome
code,
around
15-16kb
size,
encoding
for
eight
predominant
proteins.
first
isolation
occurred
1954,
as
“Edmonston
strain”.
A
team
at
Boston
Children’s
Hospital
comprised
John
Franklin
Enders
others
who
isolated
from
13-year-old
serum
sample.
Alongside
Samuel
Katz
notably
Maurice
Hilleman,
this
led
development
live
attenuated
vaccine,
when
1971,
trivalent
mumps,
measles
rubella
(MMR)
vaccine
was
licensed
use
immunisation
programmes
United
States
America
(USA).
Shortly
after,
1980,
eradication
Smallpox
confirmed
by
World
Health
Organisation
(WHO),
which
had
debilitating
pathogen
20th
century.
then
considered
cause
2.6
million
deaths
each
year.
Around
1986,
haemagglutinin
(H)
protein
crystallised
_in
vitro_.
introduction
MMR
previously
after
reduced
mortality
110,000
annually.
rates
since
2017
have
rising
largely
preventable
through
programs
evoke
immune
system
responses.
(VARV)
Rinderpest
virus
(RPV),
member
same
Morbillivirus
genus
remain
only
animal
pathogens
eradicated.
lack
antigenic
variation
suggestive
remains
third
potentially
Here
discussion
contextual
immunological
characteristics
elucidate
further.
Language: Английский
[Short Communication] Immunology of a Morbillivirus: Measles 1954 to Current
Published: Nov. 20, 2023
Measles
is
a
virus,
abbreviated
to
MeV,
thought
have
existed
around
4000
years
ago
that
has
long
been
known
be
causal
in
infant
disease
affecting
mortality
and
remaining
public
health
issue.
The
virion
defined
biologically
within
the
Family
_Paraxmyxoviridae_,
Genus
_Morbillivirus_
Species
_MeaslesMorbillivirus.
_Similar
other
infections,
MeV
an
airborne
infection
with
particle
composed
of
negative
(-ve)
sense
single–stranded
(ss)
ribonucleic
acid
(RNA)
genome
code,
15-16kb
size,
encoding
for
eight
predominant
proteins.
first
isolation
occurred
1954
as
“Edmonston
strain”
from
David
Edmonston,
student
at
Fay
School
Boston.
lack
antigenic
variation
by
suggestive
third
pathogen
potential
eradicated
requires
further
research.
In
knowledge
immune
system
had
only
just
started
emerging.
Just
prior,
1948,
pioneer
Mark
Adams
examined
how
7
bacterial
viruses
could
inactivated
through
gas/liquid
exchange
bubbling
nitrogen
over
_Escherichia
coli.
_This
occurs
barriers
glycocalyx
endothelial
surface
layer
(GC-ESL)
together
immunological
cell
phenotypes
can
restrict
viral
replication
respiratory
epithelial
layers
affected
MeV.
Other
proteins
like
cytokines,
chemokines
well
adhesion
molecules
receptors
direct
systems.
Therefore
it
was
then
observed
preventative
chemical
inactivate
pathogenic
infection.
Here
discussion
contextual
characteristics
during
Potential
explanations
elucidate
this
regards
past,
present,
future
research
are
considered.
This
outline
will
provide
key
insights
useful
researchers,
clinicians
academics
future.
Language: Английский
[Short Communication] Immunology of a Morbillivirus: Measles 1954 to 2023
Published: Nov. 23, 2023
Measles
is
a
virus,
abbreviated
to
MeV,
thought
have
existed
around
4000
years
ago
affecting
predominantly
infants
but
also
immunocompromised
individuals
and
others
remaining
public
health
issue.
The
causal
virion
defined
biologically
within
the
Family
_Paramyxoviridae_,
Genus
_Morbillivirus_
Species
_MeaslesMorbillivirus.
_Similar
other
infections,
MeV
an
airborne
infection
with
composed
of
RNA
genome
code
encoding
for
eight
predominant
proteins.
first
isolation
occurred
in
1954
known
as
“Edmonston
strain”
from
David
Edmonston,
student
at
Fay
School
Boston.
lack
antigenic
variation
by
particle
discovered
since
suggestive
that
third
pathogen
potential
be
eradicated
requires
further
research.
In
knowledge
immune
system
had
only
just
started
emerging.
Immune
cells
traverse
barriers
glycocalyx
endothelial
surface
layer
(GC-ESL)
requiring
stimulation
restrict
viral
replication
through
challenge
respiratory
epithelial
cell
layers.
different
phenotypes
regulate
inhibitory
stimulatory
proteins
like
cytokines,
chemokines
well
adhesion
molecules
receptors
transversing
permeable
organ
tissues
lymphoid
system.
Here
discussion
contextual
innate
adaptive
responses
or
immunisation.
Potential
explanations
elucidate
this
regard
past,
present,
future
research
are
considered.
This
outline
will
provide
key
insights
useful
researchers,
clinicians
academics
future.
Language: Английский